Key facts
- Notable investors include Nantong Science and Technology Innovation Investment Group.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Yifu Technology (Shanghai)
- ·The full record, as it builds
Funding rounds
No funding rounds for Yifu Technology (Shanghai) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yifu Technology (Shanghai)
Operator of biotechnology 3D proteomics analysis and related devices intended for comprehensive tumor tissue analysis purposes. The company integrates advanced imaging systems, specialized reagents, and automated workflows for whole-tissue transparency and spatial mapping, enabling clinical researchers and healthcare providers to achieve high-resolution visualization of tumor microenvironments, improve diagnostic precision, and support personalized treatment strategies through scalable and reproducible analytical methodologies.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2019
- Employees
- 4
- Website
- yifuer.com/
- Ownership
- Privately Held (backing)
Yifu Technology (Shanghai) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yifu Technology (Shanghai) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yifu Technology (Shanghai) in its N-PORT filings yet. We sweep new filings monthly.